Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824481 | Clinical Therapeutics | 2016 | 13 Pages |
Abstract
Delafloxacin was well tolerated in healthy volunteers after single and multiple IV doses. The total systemic exposure to IV (300Â mg) and oral (450Â mg) delafloxacin is comparable, supporting that a switch between the 2 formulations is appropriate.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Randall PhD, Thomas MD, Michael BS, Susan K. PhD, Laura BS, Sue MD, Eugene MD,